
Nymox Pharmaceutical Corporation NYMX
Geschäftsbericht 2024
hinzugefügt 13.12.2025
Nymox Pharmaceutical Corporation P/CF 2011-2025 | NYMX
P/CF Jährlich Nymox Pharmaceutical Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | -14.6 | -19.2 | -26.5 | -16.8 | -27.4 | -30.2 | -23 | -2.49 | -29 | -26.6 | -25.7 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -2.49 | -30.2 | -22 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
6.13 | $ 25.27 | -2.43 % | $ 1.22 B | ||
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
-5.18 | $ 4.75 | 1.61 % | $ 788 M | ||
|
Aclaris Therapeutics
ACRS
|
-7.59 | $ 3.26 | -3.12 % | $ 252 M | ||
|
AlloVir
ALVR
|
-0.723 | - | 4.14 % | $ 49.1 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-14.6 | - | -15.15 % | $ 60.3 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Kamada Ltd.
KMDA
|
-30.7 | $ 7.03 | 0.14 % | $ 260 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
-17.6 | $ 220.27 | 4.81 % | $ 5 B | ||
|
Albireo Pharma
ALBO
|
-5 | - | -0.23 % | $ 916 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | - | - | $ 7.46 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-1.4 | $ 0.91 | -5.01 % | $ 18.7 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-413 | $ 0.28 | -2.28 % | $ 609 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-94.9 | $ 3.3 | -3.51 % | $ 7.94 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
AstraZeneca PLC
AZN
|
13.6 | $ 89.78 | -0.57 % | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
Anika Therapeutics
ANIK
|
-209 | $ 9.57 | 0.84 % | $ 140 M | ||
|
Brickell Biotech
BBI
|
-2.62 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
-0.323 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
-2.46 | - | -7.31 % | $ 87 M | ||
|
Benitec Biopharma
BNTC
|
-23.6 | $ 12.05 | -7.06 % | $ 496 M | ||
|
Aytu BioScience
AYTU
|
-8.14 | $ 2.34 | 2.59 % | $ 14.7 M | ||
|
Arena Pharmaceuticals
ARNA
|
-12.5 | - | -6.81 % | $ 3.04 B | ||
|
Aptorum Group Limited
APM
|
-3.44 | $ 1.29 | -3.01 % | $ 7.03 M | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Baudax Bio
BXRX
|
-0.028 | - | 0.59 % | $ 63 K | ||
|
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Catalyst Biosciences
CBIO
|
1.3 | $ 14.01 | -8.49 % | $ 922 M | ||
|
ChromaDex Corporation
CDXC
|
35.6 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
97.5 | $ 566.18 | -2.56 % | $ 42.9 B | ||
|
Cerus Corporation
CERS
|
26.5 | $ 2.16 | 0.47 % | $ 399 M | ||
|
Checkpoint Therapeutics
CKPT
|
-5.15 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-0.185 | - | -16.75 % | $ 25.8 M | ||
|
Clovis Oncology
CLVS
|
-1.18 | - | -7.23 % | $ 13 M | ||
|
Biogen
BIIB
|
6.73 | $ 174.42 | 1.11 % | $ 25.4 B | ||
|
BioVie
BIVI
|
-0.128 | $ 1.42 | -5.96 % | $ 2.1 M | ||
|
Celldex Therapeutics
CLDX
|
-0.00833 | $ 27.36 | -2.09 % | $ 1.76 M | ||
|
Cortexyme
CRTX
|
-3.83 | - | -1.05 % | $ 67.1 M | ||
|
Cellectar Biosciences
CLRB
|
-1.37 | $ 3.63 | -3.97 % | $ 44.4 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-8.18 | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.3 | $ 11.54 | 0.87 % | $ 746 M |